Monday Shampoo hair loss concerns have spread widely on social media, with some users reporting increased shedding after switching to the brand. While no UK regulatory body — including the MHRA or NICE — has established a confirmed link between Monday Shampoo and clinically significant hair loss, individual ingredient sensitivities and coincidental timing can make the connection seem convincing. This article examines the evidence, explores the key ingredients, outlines the most common true causes of hair shedding, and explains when to seek professional advice from a GP or dermatologist.

Can Monday Shampoo Cause or Contribute to Hair Loss?

No UK regulatory body has confirmed a causal link between Monday Shampoo and hair loss; increased shedding after switching products is more likely due to coincidental telogen effluvium or heightened awareness of normal daily shedding.

Not sure if this is normal? Chat with one of our pharmacists →

Monday Shampoo is a popular haircare brand that has gained significant attention on social media, particularly among younger consumers. Some users have reported experiencing increased hair shedding or scalp irritation after using Monday products, prompting questions about whether the shampoo could be contributing to hair loss. It is important to approach this topic carefully: there is no official regulatory link — from the MHRA, NICE, or any other UK health authority — between Monday Shampoo and clinically confirmed hair loss.

An apparent increase in shedding after switching to a new shampoo is not uncommon, but the evidence that shampoos directly alter the hair growth cycle is limited. A more likely explanation is coincidental telogen effluvium (see below) or heightened awareness of normal daily shedding following a product change. In most cases, any perceived increase in shedding resolves within a few weeks.

That said, individual sensitivities to specific ingredients — particularly fragrances or preservatives — can occasionally trigger scalp inflammation or contact dermatitis. If persistent and left unaddressed, scalp inflammation may theoretically affect the follicular environment. This does not mean Monday Shampoo is inherently harmful; rather, it highlights that any cosmetic product can cause a reaction in susceptible individuals.

If you notice sustained or significant hair loss after introducing a new shampoo, it is worth investigating further rather than assuming the product is the sole cause. You should also be aware of red flags that warrant prompt medical assessment, including sudden patchy hair loss, scalp pain or tenderness, pustules, crusting, scarring, or — in children — black dots on the scalp or associated lymph node swelling, as these may suggest conditions such as tinea capitis or scarring alopecia requiring urgent review.

For further information, see the NHS hair loss (alopecia) page and NICE Clinical Knowledge Summary (CKS): Alopecia.

Key Ingredients in Monday Shampoo and Their Effects on the Scalp

Monday Shampoo ingredients such as SLES, niacinamide, biotin, and silicones are not known to directly cause hair follicle damage, though fragrance compounds can trigger allergic contact dermatitis in sensitive individuals.

Understanding the formulation of Monday Shampoo can help contextualise any concerns about scalp health. Monday products are available in several variants with differing formulations; ingredient lists vary between SKUs. Rather than assuming a specific surfactant is present, always check the full INCI (International Nomenclature of Cosmetic Ingredients) list on the product packaging or the brand's UK website, as formulations may differ from those sold in other markets.

Many shampoos — including some Monday variants — use sodium laureth sulphate (SLES) or alternative surfactants such as olefin sulfonates as their primary cleansing agents. Sodium lauryl sulphate (SLS) is used in some formulations but not all; several Monday products are marketed as SLS-free. Under the UK Cosmetics Regulation (retained from EU Cosmetics Regulation 1223/2009, overseen by the Office for Product Safety and Standards, OPSS), cosmetic ingredients must be assessed for safety before use. The Scientific Committee on Consumer Safety (SCCS) has evaluated SLS and concluded it is acceptable in rinse-off products at concentrations up to 2%, though it is classified as an irritant at higher concentrations and may cause dryness or reactive sebum production in individuals with sensitive or compromised skin conditions such as eczema or psoriasis.

Monday Shampoos may also include:

• Niacinamide — a form of vitamin B3 that may support scalp barrier function

• Biotin — often marketed for hair strength; topical biotin has limited clinical evidence of efficacy, and any benefit is likely to be modest compared with addressing systemic deficiency through diet or oral supplementation

• Fragrance compounds — among the most common causes of cosmetic-related allergic contact dermatitis; individuals with known sensitivities should review the full ingredient list carefully and consider fragrance-free alternatives

• Silicones — used for smoothness and detangling; generally well tolerated

None of these ingredients are known to directly cause hair follicle damage or clinically significant hair loss in the general population. For further information on contact dermatitis from cosmetic ingredients, see the British Association of Dermatologists (BAD) patient information on contact dermatitis.

Common Causes of Hair Loss When Using New Hair Products

Hair loss coinciding with a new shampoo is most commonly explained by telogen effluvium, androgenetic alopecia, nutritional deficiencies, thyroid dysfunction, or medications — not the product itself.

When hair loss appears to coincide with starting a new shampoo, it is easy to draw a direct causal link — but the reality is often more complex. Hair loss has numerous potential causes, many of which may be entirely unrelated to the product in question.

Telogen effluvium is one of the most frequently overlooked explanations. This is a temporary form of diffuse hair shedding triggered by physiological stress — such as recent illness (including COVID-19), nutritional deficiency, hormonal changes (including postpartum changes), or significant emotional stress — that typically manifests two to three months after the triggering event. Because the timing may coincide with a product change, the shampoo is often blamed incorrectly.

Other common causes of hair loss to consider include:

• Androgenetic alopecia (male or female pattern hair loss) — a genetic, progressive condition unrelated to product use

• Nutritional deficiencies — particularly iron and ferritin; zinc and B12 may also be relevant in some cases. Vitamin D deficiency has been associated with hair loss in some studies, though the evidence is inconsistent and it is not considered a primary cause in most cases

• Thyroid dysfunction — both hypothyroidism and hyperthyroidism can cause diffuse shedding

• Medications — certain drugs including retinoids, beta-blockers, SSRIs, anticoagulants, and others can trigger telogen effluvium; review any recently started medicines with your GP or pharmacist

• Contact dermatitis — an allergic or irritant reaction to a product ingredient that causes scalp inflammation

• Scalp conditions — such as seborrhoeic dermatitis or tinea capitis, which can disrupt the follicular environment

If hair loss began shortly after introducing Monday Shampoo, a practical first step is to discontinue use for four to six weeks and monitor whether shedding improves. Keeping a simple hair loss diary — noting daily shedding, scalp symptoms, and any other health or lifestyle changes — can be a useful tool when consulting a healthcare professional.

See NICE CKS: Alopecia and the NHS hair loss page for a comprehensive overview of differential diagnoses.

When to Seek Advice from a GP or Dermatologist

See your GP if shedding persists beyond three months, occurs in patches, or is accompanied by scalp inflammation, fatigue, or weight changes; urgent review is needed if scarring alopecia or tinea capitis is suspected.

Most episodes of increased hair shedding are self-limiting and resolve without medical intervention. However, there are specific circumstances in which it is important to seek professional advice promptly, as hair loss can occasionally signal an underlying medical condition requiring investigation and treatment.

Contact your GP if:

• Hair loss is sudden, rapid, or occurring in patches (which may suggest alopecia areata)

• Shedding has continued for more than three months without improvement

• You are experiencing associated symptoms such as fatigue, weight changes, skin changes, or irregular periods

• There is visible scalp inflammation, redness, scaling, pain, or pustules

• Hair loss is affecting your mental health or quality of life significantly

Seek urgent assessment if you notice signs that may suggest scarring alopecia or tinea capitis — including scalp tenderness, crusting, scarring, black dots at follicular openings, or swollen lymph nodes, particularly in children — as these conditions require prompt specialist review.

Your GP may arrange initial investigations based on your history and examination findings. In line with NICE CKS guidance on alopecia, this may include a full blood count and serum ferritin (to assess for iron deficiency anaemia) and TSH (to exclude thyroid dysfunction) where clinically indicated. Additional tests such as vitamin D, B12, folate, or a coeliac screen may be considered where there is a specific clinical reason, but are not routinely recommended for all presentations of hair loss.

If a cosmetic product is strongly suspected as the cause, your GP can refer you to an NHS dermatologist. Patch testing to identify specific allergens or irritants can be arranged through NHS dermatology or the British Contact Dermatitis Society (BCDS) network. Please note that trichologists are non-medical practitioners and are generally accessed privately rather than through NHS referral; the NHS pathway for hair loss is via GP to dermatology.

The British Association of Dermatologists (BAD) provides patient information on alopecia areata and other hair loss conditions. Do not delay seeking advice if you are concerned — early assessment leads to better outcomes.

Choosing a Shampoo Suitable for Thinning or Sensitive Hair

Sulphate-free, fragrance-free formulations with mild surfactants such as cocamidopropyl betaine are best suited to sensitive or thinning scalps, though no over-the-counter shampoo is licensed to treat hair loss in the UK.

If you are experiencing hair thinning or have a sensitive scalp, selecting the right shampoo can make a meaningful difference to scalp comfort and hair appearance, even if it does not directly treat the underlying cause of hair loss. The goal is to cleanse effectively without stripping the scalp's natural moisture barrier or triggering inflammation.

Key features to look for in a shampoo for thinning or sensitive hair:

• Sulphate-free or low-sulphate formulations — these are gentler on the scalp and less likely to cause dryness or irritation

• Fragrance-free or hypoallergenic options — particularly important for those with a history of contact dermatitis or eczema

• Mild amphoteric surfactants — such as cocamidopropyl betaine, which is amphoteric (zwitterionic) in nature and cleanse effectively with a lower irritation profile than SLS. Mild non-ionic surfactants such as decyl glucoside or lauryl glucoside are also well tolerated alternatives

• Scalp-soothing actives — ingredients such as piroctone olamine, selenium sulphide, or ketoconazole (available in medicated shampoos) may help manage seborrhoeic dermatitis. Please note that zinc pyrithione has been prohibited in cosmetic products in the UK and EU since 2022 and should no longer appear in compliant cosmetic shampoos; if you see it listed, check the product's compliance status. Tea tree oil is sometimes included in scalp products but evidence for its efficacy is limited and it carries a risk of contact sensitisation in some individuals

• Ketoconazole 2% shampoo (e.g., Nizoral) — licensed in the UK for dandruff and seborrhoeic dermatitis of the scalp. It has been used adjunctively in androgenetic alopecia in some studies, but this is an off-licence use with limited evidence and it is not recommended in NICE guidance for this indication; always read the Summary of Product Characteristics (SmPC) available on the Electronic Medicines Compendium (EMC)

It is worth noting that no over-the-counter shampoo — including Monday Shampoo — is licensed as a medical treatment for hair loss in the UK. Products marketed for hair growth should be evaluated critically, as many claims are not substantiated by robust clinical evidence.

If you are considering a medicated approach to androgenetic alopecia, the following licensed options are available in the UK:

• Topical minoxidil (e.g., Regaine) — available over the counter for both men and women; the only topically applied treatment with a well-established evidence base for androgenetic alopecia. Its use should ideally be discussed with a healthcare professional before starting; see the SmPC on the EMC for full indications, dosing, and cautions

• Oral finasteride — a prescription-only medicine licensed for male pattern hair loss in men; not recommended for use in women, particularly those of childbearing potential, due to the risk of harm to a male foetus

If you experience any suspected side effects from medicines such as minoxidil or ketoconazole shampoo, you can report these via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk). For guidance on scalp conditions and shampoo actives, see the Primary Care Dermatology Society (PCDS) guidance on seborrhoeic dermatitis.

Experiencing these side effects? Our pharmacists can help you navigate them →

Frequently Asked Questions